A New ACR Anti IL-17 on Entheseal Biopsy in PsA axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure Best Things I Saw Today in PsA Cycling vs Switching after TNFi Failure in axSpA Improvements in Pain and Fatigue in Bimekizumab Long-term Safety Profile of Bimekizumab in axSpA and PsA Sonelokimab in PsA: Phase 2 Data Treating SpA
A New ACR Best Things I Saw Today in PsA Do TNFis and JAKis Prevent Cancer!? Hold or continue JAKi and IL-17 when receiving COVID boosters? JAK-pot! How fast do DMARDs work? JAKi Studies at ACR Poly-treatment of Polymyalgia Rheumatica? RA Roundup: Is LDA Inappropriate? What about Statins for JAKs? RA: One JAK to Rule Them All? SELECT-GCA: Efficacy and Safety of Upadacitinib "SELECT-GCA: Upadacitinib in Giant Cell Arteritis" SELECTing the right patients: upadacitinib in GCA So really, are JAKs Safe? Summary of JAKi Studies The Case for JAKi in PMR The Real Value of JAKi is Beyond RA When, What and How Long to Treat GCA & PMR Worried about CV Risk and JAKi? What about the Steroids?
A Fibroblast Renaissance A New ACR A useful urinary biomarker for lupus nephritis ANA+ and no Autoimmune Disease? Check the liver CAR-T Therapy and Lupus Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis Evaluating ANA Patterns and Titers with AI Neuropsychiatric Lupus: The Forgotten Symptoms The 2024 ACR Guidelines for Lupus Nephritis Vaccine Responses:The DMARD Counts What is MCTD? The Great Debate
A New ACR Assessing ASAS Criteria: CLASSIC Study Results Assessment and management of axSpA Assessment of axSpA Carotid Doppler Ultrasound Screening in Axial SpA Cycling vs Switching after TNFi Failure in axSpA Defining Difficult to Manage axSpA Difficult to manage AxSpA DISH in SpA Gender Differences in AxSpA Highlights in axSpA Hot Topics in axSpA Long-term Safety Profile of Bimekizumab in axSpA and PsA Machine Learning for Predicting Flares in axSpA Precision Immunotherapy in Axial SpA PREDICT-SpA: Evaluating the influence of gender on disease assessment tools Treating SpA What is a Positive MRI in Spondyloarthritis? axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure
A New ACR Apremilast Benefits and Risks in PsA Best Things I Saw Today in PsA Bimekizumab in PsA Showed Sustained Reductions in Disease Impact Biologic Monotherapy vs Combination with cDMARDs in PsA Do TNFis and JAKis Prevent Cancer!? Improvements in Pain and Fatigue in Bimekizumab Long-term Safety Profile of Bimekizumab in axSpA and PsA Potential Impact of Weight Loss Drugs in Rheumatic Diseases Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis PsA Potpourri PsA Ultrasound Updates PsA: Impact of Sex Sex Differences in Psoriatic Arthritis The Psoriatic March: PsA before PsO Apremilast in PsA: Results from Mosaic Trial Anti IL-17 on Entheseal Biopsy in PsA
Is Frequent Lab Monitoring Necessary?:Dr. Bella Mehta The Case for JAKi in PMR:Dr. David Liew Treatment Strategies in RA:Dr. Victoria Konzett What's New in Relapsing Polychondritis?:Dr. Bella Mehta Worried about CV Risk and JAKi? What about the Steroids?:Dr. David Liew
ANCA Vasculitis "Eye": Can rituximab help?:Dr. Janet Pope Apremilast in PsA: Results from Mosaic Trial:Dr. Guillermo Valenzuela Implantable Vagus Nerve Stimulator for RA:Dr. Guillermo Valenzuela Treat-to-Target Improves Fertility in Women with RA:Dr. Richard Conway
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!
ACR 24: What I learned in Sjogren's, Takayasu's and CAR-T:Dr. Janet Pope Anti IL-17 on Entheseal Biopsy in PsA:Dr. Eric Dein axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure:Dr. Brian Jaros Can We Make Clinical Trials Better?:Dr. Janet Pope Cumulative Steroid Use and Cardiovascular Events:Dr. Mrinalini Dey IL 6 Inhibitors, Frailty and Polymyalgia Rheumatica:Drs. Trish Harkins and Sebastian Sattui IVIG Treatment in Immune-mediated Necrotizing Myopathy:Drs. Caoilfhionn Connolly interviews Dr. Asim Mohamed Machine Learning for Predicting Flares in axSpA:Dr. Sheila Reyes So really, are JAKs Safe?:Dr. Janet Pope Tackling the Workforce Crisis: A shared dilemma:Drs. Mrinalini Dey, Louise Pollard and Bharat Kumar The 2024 ACR Guidelines for Lupus Nephritis:Dr. Sheila Reyes The Real Value of JAKi is Beyond RA:Dr. David Liew Vaccine Responses:The DMARD Counts:Dr. David Liew
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!
Best Things I Saw Today in PsA:Dr. Catherine Bakewell Do TNFis and JAKis Prevent Cancer!?:Dr. Richard Conway Efficacy and Safety of Nipocalimab for Sjogren's Syndrome:Dr. Mike Putman Evaluating ANA Patterns and Titers with AI:Dr. Bella Mehta Improvements in Pain and Fatigue in Bimekizumab:Dr. Philip Mease Long Term Follow up from APIPPRA:Dr. Antoni Chan talks with Dr. Andrew Cope Race Neutral PFTs in Scleroderma Improves Equity:Dr. Caoilfhionn Connolly talks with Dr. Kamini Kuchinad Summary of JAKi Studies:Dr. Peter Nash The Psoriatic March: PsA before PsO:DR. Antoni Chan Use of AI in Hand Ultrasound Scoring:Dr. Bella Mehta What is MCTD? The Great Debate:Drs. Caoilfhionn Connolly & Lisa Christopher-Stine What's The State of Biosimilars?:Drs. Eric Dein and Jonathan Kay Pred Softly: Steroids:Dr. Jiha Lee talks with Dr. Beth Wallace
Control RA, Build Stronger Bones:Dr. Jiha Lee talks with Dr. Rachel Elam Hold or continue JAKi and IL-17 when receiving COVID boosters?:Dr. Bella Mehta Long-term Safety Profile of Bimekizumab in axSpA and PsA:Dr. Philip Mease Navigating Rheumatology Care in Humanitarian Crisis Settings:Dr. Antoni Chan talks with Dr. Martha Dhzhus RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?:Dr. Eric Dein Sex Differences in Psoriatic Arthritis:Dr. Catherine Bakewell Single v Double Lung Transplants for Disease-related ILD:Dr. Eric Dein talks with Dr. Harry Hurley Sonelokimab in PsA: Phase 2 Data:Dr. Philip Mease Treating SpA:Dr. Marina Magrey
Assessment of axSpA:Dr. Antoni Chan Defining Difficult to Manage axSpA:Dr. Lihi DISH in SpA:Dr. Sheila Reyes Generative AI in Rheumatology: The Good, The Bad, The Ugly:Dr. Akhil Sood Native Americans with RA Die Young:Dr. Eric Dein Precision Immunotherapy in Axial SpA:Dr. Marina Magrey When, What and How Long to Treat GCA & PMR:Dr. Janet Pope
A Fibroblast Renaissance:Dr. Andrea Fava A useful urinary biomarker for lupus nephritis:Dr. Andrea Fava ACR Advocacy Update:Dr. Eric Dein talks with Dr. Christina Downey, ACR Government Affairs Committee, and Dr. Kaitlyn Brittan, RheumPAC Carotid Doppler Ultrasound Screening in Axial SpA:Dr. Trish Harkins discussed with Dr. Barry O'Shea Enhanced Detection of Myocarditis in Idiopathic Inflammatory Myopathies:Dr. Caoilfhionn Connolly talks with Dr. Julie Paik PsA: Impact of Sex:Dr. Arthur Kavanaugh Rethinking Lupus Care: Early Biologics, Less Steroids:Dr. Akhil Treatment Considerations for RA-ILD:Dr. Jeff Sparks with Dr. Scott Matson
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!
JAKi Studies at ACR:Dr. Peter Nash Palliative Care in Rheumatology:Dr. Jiha Lee talks with Dr. Shannon Herndon Estimating Inflammation, Damage and Patient Distress:Dr. Jack Cush talks with Dr. Ted Pincus Methotrexate and the Gut Microbiome:Dr. Jonathan Kay talks with Dr. Rebecca Blank Poly-treatment of Polymyalgia Rheumatica?:Dr. Janet Pope Predicting Flares in Rheumatoid Arthritis:Dr. Jonathan Kay interviews Dr. John Isaacs "Changing Mindsets about Methotrexate Side Effects":Dr. Mrinalini Dey Biologic Monotherapy vs Combination with cDMARDs in PsA:Dr. Adela Castro Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis:Dr. Mike Putman ANA+ and no Autoimmune Disease? Check the liver:Dr. Janet Pope SELECTing the right patients: upadacitinib in GCA:Dr. Brian Jaros Neuropsychiatric Lupus: The Forgotten Symptoms:Dr. Mrinalini Dey talks with Dr. Chris Wincup
Bimekizumab in PsA Showed Sustained Reductions in Disease Impact:Dr. Eric Dein talks with Dr. Ana-Marie Orbai CAR-T Therapy and Lupus:Dr. Akhil Sood talks with Dr. Chris Wincup Cycling vs Switching after TNFi Failure in axSpA:Dr. Lihi Eder Difficult to manage AxSpA:Dr. Sheila Reyes talks with Dr. Denis Poddubnyy Gender Differences in AxSpA:Dr. Adela Castro Metabolic Dysregulation and RA Interstitial Lung Disease:Dr. Mrinalini Dey PsA Ultrasound Updates:Dr. Catherine Bakewell and Dr. Lihi Eder SELECT-GCA: Efficacy and Safety of Upadacitinib:Dr. Richard Conway
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!
Aging Gracefully in Managing Rheumatic Diseases:Dr. Mrinalini Dey interviews Dr. Elena Myasoedova Apremilast Benefits and Risks in PsA:Dr. Akhil Sood Assessing ASAS Criteria: CLASSIC Study Results:Dr. Adela Castro Assessment and management of axSpA:Dr. Antoni Chan Disease Activity in RA-ILD:Dr. Richard Conway Finding the Right Combination Therapy in RA:Dr. Jonathan Kay interviews Dr. Ernest Choy Highlights in axSpA:Dr. Marina Magrey Hot Topics in axSpA:Dr. Marina Magrey Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis:Dr. Antoni Chan interviews Dr. Catherine Bakewell PsA Potpourri:Dr. Arthur Kavanaugh RA Treatment Adherence: Is decision making really shared?:Dr. Jonathan Kay interviews Dr. Cécile Gaujoux-Viala RA: One JAK to Rule Them All?:Dr. Brian Jaros What is a Positive MRI in Spondyloarthritis?:Dr. Sheila Reyes interviews Dr. Walter Maksymowych
JAK-pot! How fast do DMARDs work?:Dr. Mike Putman and Dr. Kim Lauper Paraoxonase-1: Possible Biomarker for Progression to RA:Dr. Jonathan Kay Potential Impact of Weight Loss Drugs in Rheumatic Diseases:Dr. Arthur Kavanaugh PREDICT-SpA: Evaluating the influence of gender on disease assessment tools:Dr. Sheila Reyes SELECT-GCA: Upadacitinib in Giant Cell Arteritis:Dr. Mike Putman Too Many CAR-Ts for Horses?:Dr. Pope Transplant-free Survival Predictors in Idiopathic Inflammatory Myopathies-ILD:Dr. Gaby Martinez